InvestorsHub Logo
icon url

attilathehunt

02/26/24 12:03 PM

#674732 RE: georgebailey #674726

100 per month and 1200 annually




I don't think the MHRA would approve with so a low number of treatments.

The MHRA KNOWS the demands for treatments not only with GBM but also with CU.

Thus I believe, the potential of 144,000 is closer to reality.
icon url

eagle8

02/26/24 2:40 PM

#674770 RE: georgebailey #674726

Thanks for your response georgebaily.
As long as there is no real clarity from LP or Dr. Bosch, it remains a matter of speculation as to what the correct number per year is.
So not a fact.

GLTU
Bullish
Bullish
icon url

skitahoe

02/26/24 2:50 PM

#674774 RE: georgebailey #674726

Does it really matter precisely what Sawston can make. Worldwide demand is going to be substantially greater, additional production will come from the expansion of Sawston and bringing other resources on line. Whether it is CRL or others, the demand will be met by building up the suppliers capable of making the vaccine.

Gary